PMGC HOLDINGS INC. Common Stock and Additional Paid-In Capital
PMGC HOLDINGS INC. (ELAB) had Common Stock and Additional Paid-In Capital of $492.94 thousand as of 2025-04-30, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStocksIncludingAdditionalPaidInCapital · last filed 2026-03-30
- 2025-04-30: Common Stocks, Including Additional Paid in Capital $492.94K.
- 2024-09-24: Common Stocks, Including Additional Paid in Capital $7.04M; Common Stocks, Including Additional Paid in Capital as first filed $7.04M.
- 2024-08-02: Common Stocks, Including Additional Paid in Capital $325.82K; Common Stocks, Including Additional Paid in Capital as first filed $325.69K.
- 2024-05-03: Common Stocks, Including Additional Paid in Capital $1.12M; Common Stocks, Including Additional Paid in Capital as first filed $1.12M.
| Period end | Common Stocks, Including Additional Paid in Capital | Common Stocks, Including Additional Paid in Capital as first filed |
|---|---|---|
| 2025-04-30 | $492.94K 10-K · filed 2026-03-30 | |
| 2024-09-24 | $7.04M 10-K · filed 2025-03-28 | $7.04M 10-Q · filed 2024-11-14 |
| 2024-08-02 | $325.82K 10-K · filed 2025-03-28 | $325.69K 10-Q · filed 2024-11-14 |
| 2024-05-03 | $1.12M 10-K · filed 2026-03-30 | $1.12M 10-Q · filed 2024-08-14 |
| 2024-04-30 | $492.94K 10-K · filed 2025-03-28 | $492.85K 10-Q · filed 2024-08-14 |
| 2023-09-13 | $250.00K 10-K · filed 2025-03-28 | $250.00K 10-Q · filed 2024-11-14 |
| 2023-08-25 | $140.00K 10-K · filed 2025-03-28 | $140.00K 10-Q · filed 2024-11-14 |
| 2023-04-14 | $293.59K 10-K · filed 2025-03-28 | $293.58K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |